Miracle
Accelerate Clinical Trials with Automated Insights. Goodbye Spreadsheet Trackers, Hello Transparency & Efficiency.
Accelerate Clinical Trials with Automated Insights. Goodbye Spreadsheet Trackers, Hello Transparency & Efficiency.
Miracle aims to revolutionize the clinical trial process by providing automated, real-time insights, allowing biopharma companies to accelerate their clinical trials. By integrating various clinical trial data sources into a unified, real-time dashboard, including EDC, IRT, labs, PV/safety database, study websites, and vendor/CRO reports, Miracle eliminates the need for tedious spreadsheet trackers. Founded in 2022 and headquartered in the United States, the startup recently secured a $500.00K Pre Seed Round investment on 05 April 2023 from Y Combinator and North South Ventures, demonstrating support from renowned investors. The company's dedication to transparency, efficiency, and customer success stories positions it as a promising player within the Health Care and Pharmaceutical industries. For more details, visit their website at here.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $500.00K | 2 |
|
05 Apr 2023 |
We care about your data, and we'd love to use cookies make your experience better.
